| Market Cap | 86.64M | P/E | - | EPS this Y | 49.50% | Ern Qtrly Grth | - |
| Income | -34.27M | Forward P/E | -3.45 | EPS next Y | 23.60% | 50D Avg Chg | -7.00% |
| Sales | 34.94M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -23.00% |
| Dividend | N/A | Price/Book | 0.94 | EPS next 5Y | - | 52W High Chg | -61.00% |
| Recommedations | 2.00 | Quick Ratio | 3.13 | Shares Outstanding | 53.30M | 52W Low Chg | 90.00% |
| Insider Own | 9.33% | ROA | -15.10% | Shares Float | 8.54M | Beta | 0.44 |
| Inst Own | 81.81% | ROE | -41.51% | Shares Shorted/Prior | 346.09K/333.75K | Price | 3.07 |
| Gross Margin | 22.38% | Profit Margin | -98.08% | Avg. Volume | 59,775 | Target Price | 5.50 |
| Oper. Margin | -53.05% | Earnings Date | - | Volume | 7,039 | Change | -5.25% |
Alpha Teknova, Inc. produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.
| Stephens & Co. | Overweight | Jul 10, 24 |
| Stephens & Co. | Overweight | May 14, 24 |
| BTIG | Neutral | Mar 12, 24 |
| Keybanc | Sector Weight | Jul 12, 23 |
| Stephens & Co. | Overweight | Aug 11, 22 |
| Stephens & Co. | Overweight | Mar 16, 22 |
| Stephens & Co. | Overweight | Jul 20, 21 |
| Cowen & Co. | Outperform | Jul 20, 21 |
| BTIG | Buy | Jul 20, 21 |
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Gelhaus Ken | Chief Commercial Off.. Chief Commercial Officer | Nov 30 | Buy | 1.734 | 3,587 | 6,220 | 22,924 | 12/01/23 |
| Telegraph Hill Partners IV, L.... | Director Director | Sep 19 | Buy | 1.85 | 8,108,107 | 14,999,998 | 3,761,132 | 09/21/23 |
| Terrill Damon | General Counsel and.. General Counsel and CCO | Sep 19 | Buy | 1.85 | 27,027 | 50,000 | 41,027 | 09/21/23 |
| MACKOWSKI J MATTHEW | Director Director | Sep 19 | Buy | 1.85 | 810,810 | 1,499,998 | 810,810 | 09/21/23 |
| Lowell Matthew | Chief Financial Offi.. Chief Financial Officer | Sep 19 | Buy | 1.85 | 54,054 | 100,000 | 88,054 | 09/21/23 |
| Gunstream Stephen | President and CEO President and CEO | Sep 19 | Buy | 1.85 | 54,054 | 100,000 | 162,852 | 09/21/23 |
| Davis Ted | Director Director | May 26 | Buy | 3.22 | 2,000 | 6,440 | 1,888,419 | 05/31/23 |
| Davis Irene | Director Director | May 26 | Buy | 3.22 | 2,000 | 6,440 | 1,888,419 | 05/31/23 |
| Hood Lisa | Chief People Officer Chief People Officer | May 17 | Sell | 2.0362 | 3,119 | 6,351 | 45,234 | 05/17/23 |
| Gunstream Stephen | President and CEO President and CEO | May 12 | Buy | 1.666 | 4,665 | 7,772 | 108,798 | 05/16/23 |
| Gelhaus Ken | Chief Commercial Off.. Chief Commercial Officer | May 12 | Buy | 1.666 | 3,915 | 6,522 | 19,337 | 05/16/23 |
| Hood Lisa | Chief People Officer Chief People Officer | May 12 | Buy | 1.666 | 3,119 | 5,196 | 48,353 | 05/16/23 |
| Hood Lisa | Chief People Officer Chief People Officer | May 13 | Buy | 7.58 | 2,818 | 21,360 | 33,280 | 11/17/22 |
| Hood Lisa | Chief People Officer Chief People Officer | May 13 | Sell | 5.28 | 2,046 | 10,803 | 31,234 | 11/17/22 |
| Gunstream Stephen | President and CEO President and CEO | May 13 | Buy | 7.58 | 3,008 | 22,801 | 61,008 | 11/17/22 |
| Gelhaus Ken | Chief Commercial Off.. Chief Commercial Officer | Nov 14 | Buy | 4.233 | 1,422 | 6,019 | 1,422 | 11/17/22 |
| MACKOWSKI J MATTHEW | Director Director | Aug 24 | Buy | 4.98 | 10,000 | 49,800 | 5,000 | 08/25/22 |
| Gunstream Stephen | President and CEO President and CEO | Aug 15 | Buy | 5.1299 | 18,000 | 92,338 | 18,000 | 08/15/22 |
| Lowell Matthew | Chief Financial Offi.. Chief Financial Officer | May 20 | Buy | 9.4477 | 10,000 | 94,477 | 10,000 | 05/23/22 |